Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
105.97
-1.30 (-1.21%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
AbbVie (ABBV): An Undervalued Dividend Aristocrat
May 25, 2021
AbbVie Inc (ABBV) has an established eight-year track record of producing outstanding returns and superior dividend growth. Strong cash flow will enable ABBV to deleverage the balance sheet and support...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...
Via
Benzinga
Earnings Scheduled For May 11, 2021
May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is...
Via
Benzinga
Abbott (ABT) Q1 Earnings And Revenues Miss Estimates
April 20, 2021
Abbott came out with quarterly earnings of $1.32 per share, missing the Zacks Consensus Estimate of $1.33 per share.
Via
Talk Markets
15 Blue-Chip Dividend Growth Stocks: Love The Businesses Hate The Stocks
May 25, 2021
I love blue-chip dividend growth stocks that consistently grow their businesses and their dividends year after year.
Via
Talk Markets
The Power and Precision of BioSig's PURE EP™ System in the Electrophysiology (EP) Market
May 24, 2021
Arrhythmia, a condition that causes the heart to beat with an irregular or abnormal rhythm, is the fourth leading disease in the United States. Untreated or undiagnosed,...
Via
Benzinga
A Quartet Of Aristocrats
May 23, 2021
If we assembled a group of blue-chip stocks for income investors, it would likely resemble the Dividend Aristocrats, which are S&P 500 Index stocks that have raised their dividends for at least 25...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Stop Checking Your Portfolio: How to Invest for the Long Term During a Market Crash
May 23, 2021
Crashes aren't very frightening if you're mentally and financially prepared.
Via
The Motley Fool
The Best Dividend Aristocrats to Buy With $500 Right Now
May 23, 2021
You'll even have a little cash left over after buying these great dividend stocks.
Via
The Motley Fool
Abbott's Navitor Aortic Heart Valve Replacement Scores European Approval
May 17, 2021
Abbott Laboratories’ (NYSE: ABT) Navitor transcatheter aortic valve implantation (TAVI) system has received a CE mark, making it available in Europe to those...
Via
Benzinga
4 Buy-Rated Growth Stocks To Snatch Up In May
May 16, 2021
Even though growth stocks fell out of favor this year with investors who chose to rotate to cyclical stocks to capitalize on the economic recovery, some stocks are still solid bets considering their...
Via
Talk Markets
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
May 13, 2021
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com.
Via
Investor's Business Daily
P/E Ratio Insights for Abbott Laboratories
May 12, 2021
Looking into the current session, Abbott Laboratories Inc. (NYSE:ABT) is trading at $117.26, after a 0.94% decrease. Over the past month, the stock decreased by 3.49%, but...
Via
Benzinga
Why Vaccines Might Not Spell Downturn For Covid Testing Firms
May 07, 2021
Investors should hold off permanently rebranding diagnostics stocks as coronavirus stocks, experts say. There's a chance their future could be much bigger.
Via
Investor's Business Daily
Exposures
COVID-19
Why Abbott Labs' Sizzling Growth Could Taper Off
May 04, 2021
There's one key growth driver that's likely to diminish in importance.
Via
The Motley Fool
2 Top Stocks to Buy and Hold for 10 Years
May 04, 2021
Our constant need for medical products will be a major growth driver for these healthcare giants.
Via
The Motley Fool
3 Top Healthcare Stocks to Buy and Hold for the Next 10 Years
April 28, 2021
From dividends to growth to overall stability, these stocks will give your portfolio a great mix.
Via
The Motley Fool
Exposures
COVID-19
AbbVie- A High Dividend Opportunity
April 24, 2021
AbbVie (ABBV) is the seventh-largest pharmaceutical company on the globe in terms of revenue; the company is also a Dividend Aristocrat, having nearly a half-century of dividend growth to its...
Via
Talk Markets
3 Things to Cheer About in Abbott's Earnings Report
April 22, 2021
And they all will lead to revenue growth.
Via
The Motley Fool
Exposures
COVID-19
Stock Market Rally Retreats, Bitcoin Dives Amid Biden Capital Gains Tax Plan; Netflix, Snap, United Airlines In Focus
April 23, 2021
The stock market rally fell modestly with President Biden set to propose a big capital gains tax hike on the wealthy. Bitcoin plunged below $50,000.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Does Biogen Stand A Chance Of Topping Bearish First-Quarter Views?
April 21, 2021
Biogen stock could enjoy some upside Thursday if it outperforms Wall Street's bearish expectations for steep declines in first-quarter sales and earnings.
Via
Investor's Business Daily
Disappointing Subscriber Numbers Hit Netflix Shares, Weighing On Nasdaq Early
April 21, 2021
Other than earnings, we’ve had almost no numbers to crunch so far this week. That changes starting today. Weekly crude inventories come out later this morning,...
Via
Benzinga
Abbott Laboratories: Debt Insights
April 21, 2021
Shares of Abbott Laboratories (NYSE:ABT) increased by 5.04% in the past three months. Before we understand the importance of debt, let us look at how much debt Abbott...
Via
Benzinga
Abbott Laboratories Shares Sink on Mixed Q1; New Dividend Declared
April 20, 2021
COVID-testing products helped beef up revenue and profitability.
Via
The Motley Fool
Abbott Laboratories (ABT) Q1 2021 Earnings Call Transcript
April 20, 2021
ABT earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Abbott's Sales Soared in Q1, but Not Enough to Satisfy Wall Street
April 20, 2021
The healthcare company's COVID-19 tests continued to drive its growth.
Via
The Motley Fool
Exposures
COVID-19
Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology
April 20, 2021
The following article is sponsored by Biotricity Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its...
Via
Benzinga
Abbott Stock Is Trading Lower After Q1 Sales Shy Of Estimates
April 20, 2021
Abbott Laboratories (NYSE: ABT) has reported Q1 adjusted earnings of $1.32 per share on $10.5 billion in sales for its first quarter. Though EPS was above the...
Via
Benzinga
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
April 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...
Via
Benzinga
Abbott Laboratories: Q1 Earnings Insights
April 20, 2021
Shares of Abbott Laboratories (NYSE:ABT) moved higher by 0.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 103.08...
Via
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.